Anika Therapeutics Inc — Quarterly Financial Statistics (NASDAQ:ANIK) | MetaTrader

Open full chart

Financials

Overview Estratto Conto Statistics Dividends

Quarterly Annual

Cash from operating activities 2.63 M1.58 M130 K189 K6.23 M 8.13 M Cash from investing activities 1.82 M1.31 M1.67 M-539 K-534 K 1.91 M Cash from financing activities 3.99 M5.35 M5.44 M-179 K13 K 10.63 M Free cash flow 1.41 M275 K-2.69 M-1.28 M4.34 M 648 K

Notizie

Anika Therapeutics (ANIK) Q4 Earnings and Revenues Beat Estimates

Anika Q4 2025: l’impennata commerciale compensa il calo OEM

Anika Q4 2025 slides: commercial surge offsets OEM decline

Anika earnings beat by $0.45, revenue topped estimates

Lumicell appoints Cheryl Blanchard to board of directors

Anika Therapeutics names Stephen Griffin as new CEO

Slide di Anika del Q3 2025: La crescita commerciale compensa il calo OEM

Anika Q3 2025 slides: Commercial growth offsets OEM decline

Anika Therapeutics (ANIK) Q3 Earnings and Revenues Top Estimates

Anika earnings beat by $0.22, revenue was in line with estimates

Arcturus Therapeutics (ARCT) Surges 8.7%: Is This an Indication of Further Gains?

Wall Street Analysts See a 98.59% Upside in Anika (ANIK): Can the Stock Really Move This High?